{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T17:01:34Z","timestamp":1773334894790,"version":"3.50.1"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:00:00Z","timestamp":1759536000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008247","name":"University of Otago","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003524","name":"Ministry of Business, Innovation and Employment","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003524","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJID Regions"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijregi.2025.100784","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:40:52Z","timestamp":1759797652000},"page":"100784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prevention of rheumatic heart disease in New Zealand: High-dose subcutaneous benzathine penicillin is cost-saving compared with traditional intramuscular injections"],"prefix":"10.1016","volume":"17","author":[{"given":"William","family":"Leung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurens","family":"Manning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3461-7223","authenticated-orcid":false,"given":"Julie","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijregi.2025.100784_bib0001","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/QCO.0b013e3283511d27","article-title":"Streptococcal skin infection and rheumatic heart disease","volume":"25","author":"Parks","year":"2012","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.ijregi.2025.100784_bib0002","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.84","article-title":"Acute rheumatic fever and rheumatic heart disease","volume":"2","author":"Carapetis","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ijregi.2025.100784_bib0003","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMp078039","article-title":"Rheumatic heart disease in developing countries","volume":"357","author":"Carapetis","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijregi.2025.100784_bib0004","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3201\/eid2701.191791","article-title":"Rising ethnic inequalities in acute rheumatic fever and rheumatic heart disease, New Zealand, 2000\u20132018","volume":"27","author":"Bennett","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijregi.2025.100784_bib0005","doi-asserted-by":"crossref","first-page":"S301","DOI":"10.1016\/j.hlc.2022.06.515","article-title":"Subcutaneous infusions of high-dose benzathine penicillin g (SCIP) is safe, tolerable and potentially suitable for less frequent dosing for rheumatic heart disease secondary prophylaxis","volume":"31","author":"Kado","year":"2022","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.ijregi.2025.100784_bib0006","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1093\/jac\/dkac231","article-title":"Population pharmacokinetic study of benzathine penicillin g administration in Indigenous children and young adults with rheumatic heart disease in the Northern Territory","volume":"77","author":"Kado","year":"2022","journal-title":"Australia. J Antimicrob Chemother"},{"key":"10.1016\/j.ijregi.2025.100784_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2025.106506","article-title":"High dose, subcutaneous injections of benzathine penicillin g (SCIP) to prevent rheumatic fever: a single arm, phase IIa trial of safety and pharmacokinetics","volume":"91","author":"Bennett","year":"2025","journal-title":"J Infect"},{"key":"10.1016\/j.ijregi.2025.100784_bib0008","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/jech.2007.070037","article-title":"Retrofitting houses with insulation: a cost\u2013benefit analysis of a randomised community trial","volume":"63","author":"Chapman","year":"2009","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.ijregi.2025.100784_bib0009","series-title":"Rheum Fever Rheum Heart Dis 2024 Update","article-title":"Aotearoa New Zealand guidelines for the prevention, diagnosis, and management of acute","author":"Anderson","year":"2025"},{"key":"10.1016\/j.ijregi.2025.100784_bib0010","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12939-017-0700-1","article-title":"Enablers and barriers to secondary prophylaxis for rheumatic fever among M\u0101ori aged 14\u201321 in New Zealand: a framework method study","volume":"16","author":"Barker","year":"2017","journal-title":"Int J Equity Health"},{"key":"10.1016\/j.ijregi.2025.100784_bib0011","article-title":"Community schedule","year":"2024","journal-title":"Pharmac"},{"key":"10.1016\/j.ijregi.2025.100784_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0302493","article-title":"Hurts less, lasts longer\"; a qualitative study of experiences of young people receiving high-dose subcutaneous injections of benzathine penicllin G to prevent rheumatic heart disease in New Zealand","volume":"19","author":"Cooper","year":"2024","journal-title":"PLOS One"},{"key":"10.1016\/j.ijregi.2025.100784_bib0013","unstructured":"Figure.nz. Providers, https:\/\/figure.nz\/providers; 2024 [accessed 17 December 2024)."}],"container-title":["IJID Regions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772707625002188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772707625002188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:20:47Z","timestamp":1773292847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772707625002188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":13,"alternative-id":["S2772707625002188"],"URL":"https:\/\/doi.org\/10.1016\/j.ijregi.2025.100784","relation":{},"ISSN":["2772-7076"],"issn-type":[{"value":"2772-7076","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention of rheumatic heart disease in New Zealand: High-dose subcutaneous benzathine penicillin is cost-saving compared with traditional intramuscular injections","name":"articletitle","label":"Article Title"},{"value":"IJID Regions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijregi.2025.100784","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"100784"}}